Immune response of newborn BALB/c mice to Cryptosporidium infection
- PMID: 27605838
- PMCID: PMC4996248
- DOI: 10.1007/s12639-014-0635-z
Immune response of newborn BALB/c mice to Cryptosporidium infection
Abstract
Cryptosporidium parvum is a protozoan parasite which causes diarrheal in human and animals worldwide. Infection transmission has reported through oral-fecal by infectious objects through foods and drinks. In this study we explored the immune response pathway in animal model for C. parvum to develop the new treatment way. Oocysts collected from fecal positive for C. parvum and diluted about 1:5 in sucrose solution. New born BALB/c mice (3 days) divided to 2 different groups. Control group hadn't received any oocyst, the test groups received 5 × 10(5) oocysts. 5 mice selected for each control group and 11 mice chosen for each test group. Blood collected from heart bleeds in days of 6, 9, 12 and 16. Protein concentrations determined by bio-photometer. Dot blotting used to find out total antibody concentrations oocyst antigen. Among the test and the control groups, blots appeared in test group which means antibody production, but not any blot observed in the control groups. The non-characteristic proteins in serum were measured by the biophotometer. In this study, we investigated antibody serum production against C. parvum oocysts in new born BALB/c mice. The detected antibody through dot blot technique was our aims which had conjugated to our characteristic antiserum. The recorded numbers for the controls by biophotometer related to the non characteristic proteins in serum. The results of this study can used to produce polyclonal or monoclonal antibodies against cryptosporidiosis.
Keywords: BALB/c mice; Cryptosporidium parvum; Immune response.
Figures


Similar articles
-
Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.Vaccine. 1999 May 14;17(19):2453-60. doi: 10.1016/s0264-410x(98)00369-7. Vaccine. 1999. PMID: 10392628
-
Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.Vet Parasitol. 2018 Jan 30;250:7-14. doi: 10.1016/j.vetpar.2017.12.008. Epub 2017 Dec 9. Vet Parasitol. 2018. PMID: 29329627
-
[Highly Active AntiRetroviral Therapy and cryptosporidiosis].Parassitologia. 2004 Jun;46(1-2):95-9. Parassitologia. 2004. PMID: 15305695 Italian.
-
Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.J Vet Sci. 2006 Mar;7(1):47-51. doi: 10.4142/jvs.2006.7.1.47. J Vet Sci. 2006. PMID: 16434849 Free PMC article.
-
Detection of Cryptosporidium parvum oocysts by dot-blotting using monoclonal antibodies to Cryptosporidium parvum virus 40-kDa capsid protein.J Parasitol. 2008 Feb;94(1):94-8. doi: 10.1645/GE-1313.1. J Parasitol. 2008. PMID: 18372626
References
-
- Chen XM, O’Hara SP, Nelson JB, Splinter PL, Small AJ, Tietz PS, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defence responses to Cryptosporidium parvum via activation of NF-B. J Immunol. 2005;175(11):7447–7456. doi: 10.4049/jimmunol.175.11.7447. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources